Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer Receives World Health Organization Prequalification for Multi-Dose Vial Presentation of Prevenar 13®

[Business Wire] – Pfizer Inc. announced today that the World Health Organization has prequalified its four-dose, multi-dose vial presentation of Prevenar 13®* . Read more on this. , with a current market cap of $recting to http://finance.ya, ended trading at $. During today’s session, PFE traded between $ with its 52-week range being $. PFE shares are currently priced at x this year’s forecasted earnings, which makes them relatively inexpensive compared to the industry’s x earnings multiple for the same period. Consensus earnings for the current quarter by the 0 sell-side analysts covering the stock is an estimate of $ per share, which would be $0.00 worse than the year-ago quarter and a $0.00 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $ is a $0.00 worse when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $0.00 . If realized, that would be a 0.00% decrease over the year-ago quarter. More recently, d PFE from to (/fi). Previously, d PFE from to . The average price target for PFE shares is $, which is 0.00% below where the stock opened this morning. See more in (NYSE:PFE) Similar Articles: Stock Update (NYSE:AGN): Allergan Receives Complete Response Letter from FDA for Prior Approval Supplement for RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Multi-Dose Preservative-Free Bottle Stock Update (NYSE:PFE): Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference Market Update: Pfizer Inc (NYSE:PFE) – Pfizer Receives Expanded FDA Approval For IBRANCE (palbociclib) In HR+, HER2- Metastatic Breast Cancer